Literature DB >> 12454887

Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?

Sambit Sen, Rajeshwar P Mookerjee, Rajiv Jalan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454887     DOI: 10.1053/gast.2002.37303

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

Review 1.  Current Medical Treatment for Alcohol-Associated Liver Disease.

Authors:  Gustavo Ayares; Francisco Idalsoaga; Luis A Díaz; Jorge Arnold; Juan P Arab
Journal:  J Clin Exp Hepatol       Date:  2022-02-12

2.  Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: a meta-analysis.

Authors:  Sharanabasayyaswamy B Hiremath; L D Srinivas
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.